Dr Lloyd Pereira
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
28 Scholarly works
0 Projects
HIGHLIGHTS
2019
Journal article
First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427)
DOI: 10.1016/j.conctc.2019.1004092019
Conference Proceedings
Novel vaccine targeting colonic adenoma: A pre-clinical model
DOI: 10.1158/1538-7445.SABCS18-14722019
Journal article
Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical Model
DOI: 10.1007/s11605-018-4060-y2019
Conference Proceedings
EμTel-Jak2 T-ALL mouse model is dependent upon Myb function and susceptible to immune checkpoint therapy
DOI: 10.1158/2326-6074.CRICIMTEATIAACR18-A1492018
Journal article
An Update on Immunotherapy for Solid Tumors: A Review
DOI: 10.1245/s10434-018-6658-42018
Conference Proceedings
CANCER VACCINE TARGETING MYB IN COLORECTAL CANCER: FROM PRE-CLINICAL MODEL TO CLINICAL TRIAL
DOI: 10.1016/s0016-5085(18)34159-32016
Journal article
Intestinal-specific activatable Myb initiates colon tumorigenesis in mice
DOI: 10.1038/onc.2015.305
RECENT SCHOLARLY WORKS
2015
Journal article
Defective Myb function ablates Cyclin E1 expression and perturbs intestinal carcinogenesis
DOI: 10.1158/1541-7786.MCR-15-00142015
Journal article
MYB elongation is regulated by the nucleic acid binding of NFekB p50 to the intronic stem-loop region
DOI: 10.1371/journal.pone.01229192015
Journal article
Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer
DOI: 10.3389/fonc.2015.00013